Get the Stockscreener App
6.74
2.18%
-0.15
Aura Biosciences Inc stock is traded at $6.74, with a volume of 200.60K.
It is down -2.18% in the last 24 hours and up +7.67% over the past month.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
See More
Previous Close:
$6.89
Open:
$6.75
24h Volume:
200.60K
Relative Volume:
0.94
Market Cap:
$338.81M
Revenue:
-
Net Income/Loss:
$-76.41M
P/E Ratio:
-3.5104
EPS:
-1.92
Net Cash Flow:
$-64.56M
1W Performance:
-6.78%
1M Performance:
+7.67%
6M Performance:
-14.14%
1Y Performance:
-31.64%
1-Day Range:
$6.63
$6.87
1-Week Range:
$6.38
$7.4799
52-Week Range:
$4.345
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
Name
Aura Biosciences Inc
Sector
Industry
Phone
(617)500-8864
Address
80 GUEST STREET, BOSTON
Compare AURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
6.74 | 427.21M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Resumed | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | H.C. Wainwright | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Apr-17-23 | Resumed | BTIG Research | Buy |
| Jul-19-22 | Initiated | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Stock (AURA) Latest News
Is Aura Biosciences Inc. a candidate for recovery playRisk Shielded Trade Watch with Analysis - Newser
Why is Aura Biosciences Inc. stock attracting strong analyst attentionBest Dividend Insights For Fast Growth - jammulinksnews.com
How many analysts rate Aura Biosciences Inc. as a “Buy”Low Risk Recommendation With High Returns - jammulinksnews.com
Market reaction to Aura Biosciences Inc.’s recent newsSmart Risk Strategy with Entry Optimization - Newser
Why Aura Biosciences Inc. stock attracts strong analyst attentionHigh Probability Trade Outcome Prediction - Newser
New Product Launches: Will They Boost Aura Biosciences Inc. Stock in 2025Weekly Price Target Forecast and Alerts - Newser
Published on: 2025-07-31 19:55:27 - Newser
How does Aura Biosciences Inc. generate profit in a changing economyExpert Picks Report For Fast Growth - jammulinksnews.com
Sectors Driving Future Growth for Aura Biosciences Inc. StockGrowth Watchlist for Long Term Positioning - Newser
Short Term Charts Align With Long Term Uptrend in Aura Biosciences Inc.AI Based High Gain Watchlist Scanner Shared - metal.it
Regression analysis insights on Aura Biosciences Inc. performanceHigh Yield Watchlist with Filtered Picks - Newser
Published on: 2025-07-30 03:50:30 - Newser
Can a trend reversal in Aura Biosciences Inc. lead to recoveryFree Low Risk Picks for Daily Trading - Newser
Short Covering May Lift Aura Biosciences Inc. in Near TermInvestment Strategy Designed for Capital Protection - metal.it
What are the latest earnings results for Aura Biosciences Inc.Invest smarter with actionable trading signals - jammulinksnews.com
How volatile is Aura Biosciences Inc. stock compared to the marketMaximize your portfolio’s growth potential - jammulinksnews.com
How strong is Aura Biosciences Inc. company’s balance sheetMarket-beating returns - jammulinksnews.com
Aura Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayMarket Ready Callouts - metal.it
Aura Biosciences Inc. Stock Performance After Earnings: Historical InsightsInsider Level Guidance - Newser
What drives Aura Biosciences Inc. stock priceExponentially increasing returns - PrintWeekIndia
Aura Biosciences Inc. Stock Analysis and ForecastMassive wealth growth - PrintWeekIndia
Will Aura Biosciences Inc. stock benefit from AI tech trendsRapid capital growth - jammulinksnews.com
What analysts say about Aura Biosciences Inc. stockFree Technical Analysis Support - PrintWeekIndia
Can Aura Biosciences Inc. stock recover from recent declineOverwhelming financial success - jammulinksnews.com
Learn to Evaluate (AURA) using the Charts - news.stocktradersdaily.com
Is Aura Biosciences Inc. a good long term investmentHigh-performance investment picks - Autocar Professional
Non Muscle Invasive Bladder Cancer Clinical, Companies, - openPR.com
Aura Biosciences, Inc. (NASDAQ:AURA) Receives $22.00 Consensus Target Price from Brokerages - Defense World
What analysts say about OneSpan Inc. stockTremendous gains - Autocar Professional
Nauticus Robotics Inc. Stock Analysis and ForecastAccelerated profit realization - jammulinksnews.com
Aura Biosciences Inc Stock (AURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aura Biosciences Inc Stock (AURA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Johnson David Michael | Director |
May 16 '25 |
Buy |
4.90 |
20,000 |
98,000 |
166,167 |
| Gibney Anthony S | See Remarks |
May 16 '25 |
Buy |
4.90 |
50,000 |
245,000 |
58,452 |
| Gibney Anthony S | See Remarks |
May 16 '25 |
Sale |
5.15 |
1,519 |
7,823 |
56,933 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):